Objective: To test the hypothesis that there is no difference in the vertical alveolar bone levels and alveolar bone thickness around the maxillary and mandibular central incisors in surgically treated skeletal Class III malocclusion patients.
Materials and Methods:The study sample comprised 20 Korean patients with skeletal Class III malocclusion with anterior crossbite and openbite (9 male, 11 female, mean ages 24.1). Threedimensional cone beam computed tomography images were taken at least 1 month before the orthognathic surgery, and sagittal slices chosen at the labio-lingually widest point of the maxillary and mandibular right central incisor were evaluated. Measurement of the amount of vertical alveolar bone levels and alveolar bone thickness of the labial and lingual plate at the root apex was made using the SimPlant Pro 12.0 program.
Results:The mandibular incisors showed reduced vertical alveolar bone levels than the maxillary incisors, especially on the lingual side. The alveolar bone thickness was significantly greater on the lingual side in the maxillary incisors, whereas the mandibular incisors exhibited an opposite result (P Ͻ .05). The percentage of vertical bone loss to root length showed a statistically significant difference between the upper labial and lower labial alveolar bone and also between the upper lingual and lower lingual alveolar bone, showing more bone loss in the lower incisors (P Ͻ .001).
Conclusions:The hypothesis is rejected. For the skeletal Class III patients undergoing orthognathic surgery, special care should be taken to prevent or not aggravate preexisting alveolar bone loss in the anterior teeth, especially in the mandible. (Angle Orthod. 2009;79:676-682.)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.